Bannerbild German Brest Group

Data protection declaration

GBG takes the protection of your personal data very seriously. We treat your personal data as confidential and in accordance with the statutory data protection provisions and this data protection declaration.
The party responsible for the data processing (the Data Controller) is GBG Forschungs GmbH, represented by Prof. Dr. med. Sibylle Loibl (for contact details see Legal Notice).
You can contact our Data Protection Officer on privacy@gbg.de or by telephone on +4961027480-461.

Your rights

You have a right to receive information at any time and free of charge about the personal data stored about you, their origin and recipients and the purpose of the data processing as well as a right to the correction, restriction or deletion of such data. You can contact us at any time via the address shown in the Legal Notice regarding this or any other issues relating to personal data.
You have a right to complain to the relevant supervisory authority, for example the Hessian Data Protection Officer (Hessischer Datenschutzbeauftragter), Postfach 31 63, 65021 Wiesbaden, https://www.datenschutz.hessen.de.

When using this website

As a rule it is possible to use our website without providing any personal data.

Cookies
Cookies serve to make our services more user-friendly, effective and secure. The cookies that we use are “session cookies”. They will be deleted automatically
after your visit.
SSL encryption
For reasons of security and to protect the transfer of confidential content such as enquiries via the contact form, this website uses seamless SSL encryption. You can recognise an encrypted connection by the fact that the address bar of the browser changes from “http://” to “https://” and by the padlock symbol in your browser bar. This makes it harder for third parties to intercept and alter the data transmitted.
Server log files
Our website host automatically records and stores information in “server log files” that are automatically transferred to us by your browser. This information could include:

  • IP address of the accessing computer
  • Date and time of the server enquiry
  • Browser type and browser version
  • Operating system used
  • Referrer URL

After 7 days these data are anonymised and used to produce access statistics and hence to improve our web services. These data are not combined with other data sources. We reserve the right to check these data if we become aware of specific reasons to suspect illegal use.
Links to third party sites
When we refer (provide “links”) to other sites that are not located on our web server, we indicate this by means of an appropriate “External Link” symbol. As soon as you follow a link of this kind, you are leaving our area of responsibility. The data protection declaration of the relevant external service provider applies.

If you contact us

If you contact us via the contact form or by email, data provided by you, including your contact details will be stored by us for the purpose of processing your enquiry and handling any follow-up questions. We will not forward these data to third parties without your consent.
The data from the contact form will be tranmitted to us via an encrypted channel (SSL).

If you apply for a position with us

We will use your application data only for the selection procedure relating to the position for which you are applying.
Your application data wil be received by the HR department of GBG Forschungs GmbH.
Your data will be deleted six months after completion of the application process.

If you participate in one of our clinical trials

We run many different trials. The general procedure for processing data is as follows:
We process your data on the basis of your patient consent to the clinical trial and in accordance with the requirements of the Arzneimittelgesetz (AMG, German Medicines Act). You are entitled to withdraw this consent at any time without stating reason. Should you withdraw your consent, no further data will be recorded but the data recorded to date will be retained in so far as this is necessary to meet the requirements of the AMG.
The data will be processed for the purpose of conducting a clinical trial to study the effectiveness and safety of the medicines used. The data may possibly also be used for registration/approving or extension of registration of the drugs.
Your medical data is  transmitted in pseudonymised form (using only a patient number, but no name) to GBG Forschungs GmbH in Neu-Isenburg by your physician. GBG has no access to your name and address data. Only the study site treating you knows your name.
These medical data are retained after the end or discontinuation of the trial in accordance with statutory provisions relating to clinical trials (currently at least ten years). In the event of scientific publication, only anonymised data will be published.
If you have any questions regarding your stored data, please first contact the study site treating you. The site may forward your enquiry to GBG.
For further information, in particular about the institutions involved, please see the patient information document and the declaration of consent relating to your trial.

News

  • 15.10.2018 GBG Research at ESMO

    Data of several GBG trials and translational research projects will be presented at the upcoming ESMO 2018 Congress, which will take place from 19 to 23 October in Munich, Germany.

    Mehr ...
  • 11.10.2018 BIG newsletter no 9 is out

    We’re delighted to announce that the BIG newsletter BIG Research in Focus, Issue 9 is out and has been published on BIG’s website.

    Mehr ...
  • 27.09.2018 GBG-Jahrestreffen - Save the Date

    GBG-Jahrestreffen - Save the Date

    Das GBG Jahrestreffen 2019 wird am 14. & 15. März 2019 in Niederrad Frankfurt am Main stattfinden.

    Mehr ...
  • 27.09.2018 Paper of the month: models for pCR

    Paper of the month: models for pCR

    A statistical research study that aimed to develop an empirical model for predicting the magnitude of the treatment effects on survival endpoints based on the treatment effects on pathological complete response (pCR) has been published in the Contemporary Clinical Trials.

    Mehr ...
  • 11.09.2018 BCC-Breast Cancer Conference 2019 in Vienna

    BCC-Breast Cancer Conference 2019 in Vienna

    The 16th St. Gallen International Breast Cancer Conference 2019 in Vienna is less than seven months away.

    Mehr ...

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd